课题基金 / 基金详情

项目摘要

项目成果

Mamuka Kvaratskhelia的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Key steps of early HIV-1 infection include reverse transcription, nuclear import of replication complexes and transport to nuclear speckles followed by viral DNA integration into host genome. At some point before integration, the capsid shell surrounding the viral ribonucleoprotein complex must disassemble (uncoat) to release the viral pre-integration complexes. It is currently unclear where in the cell uncoating occurs and whether the capsid (CA) protein is progressively or synchronously lost from the capsid shell, yet optimal core stability is essential for evading the host innate immune responses and for nuclear import of functional viral complexes. Highly divergent findings regarding HIV-1 uncoating have been reported by several groups based upon the visualization of single virus uncoating in live cells. These conflicting results stem, in part, from the use of indirect CA labeling approaches and lack of minimally invasive direct fluorescent labeling of HIV-1 capsid. We hypothesize that HIV-1 uncoating is a multi-step process that involves permeabilization of the capsid shell in the cytoplasm, remodeling at the nuclear pore, and loss of CA in the nucleus. We will use a novel minimally invasive direct CA labeling strategy, which is based on site-directed incorporation of non-canonical amino acids and click- labeling with an organic dye, to elucidate single HIV-1 core permeabilization and uncoating events resulting to infection (Aim 1). Another gap in knowledge pertains to post-uncoating processes leading to HIV-1 integration and sub-nuclear compartments where integration occurs. We hypothesize that the viral pre-integration complex separates from the capsid shell and travels to the edge of a nuclear speckle where it engages the integrase- binding host factor LEDGF/p75 for integration into host genome. We will employ a novel live-cell single viral DNA visualization technology to track nuclear transport and productive integration of single viral complexes that establish actively transcribing viral RNA foci (Aim 2). Finally, we will use a powerful panel of biochemical, biophysical, structural biology, virology, and microscopy techniques to characterize a novel HIV-1 CA binding host factor, RBM14, which we hypothesize to modulate pre-integration steps of infection after nuclear import (Aim 3). These experiments are expected to elucidate the controversial HIV-1 uncoating process, reveal the dynamic events leading to productive integration and sites of integration, as well as delineate the role of RBM14- capsid interactions in early infection, thus informing novel antiviral strategies.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
一种新表型将 HIV-1 衣壳稳定性与 cGAS 介导的 DNA 传感联系起来。
DOI: 10.1128/jvi.00706-19
发表时间: 2019
期刊: Journal of virology
影响因子: 5.4
作者: [Siddiqui,MohammadAdnan, Saito,Akatsuki, Halambage,UpulD, Ferhadian,Damien, Fischer,DouglasK, Francis,AshwanthC, Melikyan,GregoryB, Ambrose,Zandrea, Aiken,Christopher, Yamashita,Masahiro]
通讯作者: Yamashita,Masahiro
DOI: 10.1021/acsnano.3c07678
发表时间: 2024-01-30
期刊: ACS NANO
影响因子: 17.1
作者: [Gifford, Levi B., Melikyan, Gregory B.]
通讯作者: Melikyan, Gregory B.
DOI: 10.1371/journal.ppat.1005709
发表时间: 2016-06
期刊: PLoS pathogens
影响因子: 6.7
作者: [Francis AC, Marin M, Shi J, Aiken C, Melikyan GB]
通讯作者: Melikyan GB
DOI: 10.3390/v12111234
发表时间: 2020-10-30
期刊: Viruses
影响因子: --
作者: [Francis AC, Marin M, Prellberg MJ, Palermino-Rowland K, Melikyan GB]
通讯作者: Melikyan GB
11
    Imaging early steps of HIV-1 infection and virus-host factor interactions
    • 批准号:
      10548587
    • 项目类别:
    • 资助金额:
      $58.21万
    • 财政年份:
      2022
    • 负责人:
      Mamuka Kvaratskhelia
    • 依托单位:
    Multimeric HIV-1 Integrase Inhibitors
    • 批准号:
      10570935
    • 项目类别:
    • 资助金额:
      $49.82万
    • 财政年份:
      2019
    • 负责人:
      Mamuka Kvaratskhelia
    • 依托单位:
    Multimeric HIV-1 Integrase Inhibitors
    • 批准号:
      10348747
    • 项目类别:
    • 资助金额:
      $49.95万
    • 财政年份:
      2019
    • 负责人:
      Mamuka Kvaratskhelia
    • 依托单位:
    Multimeric HIV-1 Integrase Inhibitors
    • 批准号:
      9893809
    • 项目类别:
    • 资助金额:
      $50.2万
    • 财政年份:
      2019
    • 负责人:
      Mamuka Kvaratskhelia
    • 依托单位:
    海外基金